Showing results (61-70 of 66) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Respiratory Investigation|May 24, 2014
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802Yosuke Kawashima, Akira Inoue, Shunichi Sugawara, et al.Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Akira Inoue, Shunichi Sugawara, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2021
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective studyYoko Tsukita, Takaya Yamamoto, Hiroshi Mayahara, et al.Clinical and Translational Radiation Oncology|September 6, 2022
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non-small cell lung cancer: A multicenter retrospective cohort studyYuichiro Takeda, Yusaku Kusaba, Yoko Tsukita, et al.Thoracic Cancer|June 2, 2021
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401)Hisashi Tanaka, Yukihiro Hasegawa, Yuka Fujita, et al.Journal for Immunotherapy of Cancer|February 19, 2020
Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L)Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, et al.Pageof 7